Skip to main content

Pluri Inc.

PLUR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001158780

No open-market purchases or sales by Pluri Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $55.3K in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Pluri Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of PLUR: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders4236−6
Shares2.83M919.8K−1.91M (−67.5%)
Value$3.48M$732.6K−$2.74M (−78.9%)

New holders (2)

Institutions that held Pluri Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to PLUR in Q3 2022
InstitutionSharesValue% of portfolio
Activest Wealth Management782$1.00K0.00%
TCI Wealth Advisors, Inc.99$00.00%

Sold out (8)

Institutions that held Pluri Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of PLUR in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Shelton Capital Management128,532$158.0K
Citadel Advisors LLC106,868$131.0K
State Street Corp84,975$105.0K
Pathstone Family Office, LLC55,314$68.0K
BSW Wealth Partners14,937$18.0K
Eqis Capital Management, Inc.14,419$17.7K
Susquehanna International Group Ltd.11,137$14.0K
Kestra Advisory Services, LLC10,777$13.0K